VERSANT VENTURE CAPITAL VI, L.P. sold 21.3% of their position (260.71K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.26M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/19/2025ACC: 0000950170-25-110163
10% Owner
Since Jun 2021
-260.71K
Net shares
Net seller
$10.26M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
260.71K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−145.05K
Price / share
$39.50
Trade value
$5.73M
% of position
9.2%
8/15/2025
1.58M→1.43M
Common Stock
Indirect
Shares
−69.95K
Price / share
$39.50
Trade value
$2.76M
% of position
6.7%
8/15/2025
1.05M→977.96K
Common Stock
Direct
Shares
−30.63K
Price / share
$38.56
Trade value
$1.18M
% of position
2.1%
8/18/2025
1.43M→1.40M
Common Stock
Indirect
Shares
−15.09K
Price / share
$38.56
Trade value
$581.69K
% of position
1.5%
8/18/2025
977.96K→962.88K
Total
Net shares
−260.71K
Net value
-$10.26M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2025 | S · Sale | −145.05K | $39.50 | $5.73M | 9.2% | 1.58M | 1.43M |
| Common Stock Indirect | 8/15/2025 | S · Sale | −69.95K | $39.50 | $2.76M | 6.7% | 1.05M | 977.96K |
| Common Stock Direct | 8/18/2025 | S · Sale | −30.63K | $38.56 | $1.18M | 2.1% | 1.43M | 1.40M |
| Common Stock Indirect | 8/18/2025 | S · Sale | −15.09K | $38.56 | $581.69K | 1.5% | 977.96K | 962.88K |
| Total | −260.71K | -$10.26M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned842.16K
Total
842.16K indirect842.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 842.16K | Indirect |
| Total | 842.16K | 842.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported